tiprankstipranks
Advertisement

UDI - ETF AI Analysis

Compare

Top Page

UDI

USCF Dividend Income Fund (UDI)

Rating:73Outperform
Price Target:
UDI, the USCF Dividend Income Fund, has a solid overall rating that reflects a portfolio anchored by strong, diversified leaders like Medtronic, Johnson & Johnson, and Cisco, which benefit from healthy financial performance, innovation, and supportive earnings calls. Energy names such as ConocoPhillips and Phillips 66 add cash flow strength and dividends, though some holdings like AbbVie and Lamar Advertising face valuation and leverage concerns that slightly weigh on the fund, and investors should note the added risk from exposure to sectors like energy and financials that can be more sensitive to economic cycles.
Positive Factors
Strong Recent Performance
The fund has shown strong gains so far this year and in recent months, suggesting its strategy has been working in the current market.
Solid Top Holdings
Several of the largest positions, including major financial, health care, and energy companies, have delivered strong year-to-date results that support the ETF’s overall performance.
Broad Sector Diversification
The ETF spreads its investments across many sectors such as financials, health care, energy, real estate, and utilities, which helps reduce the impact if any one industry struggles.
Negative Factors
High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
Concentration in Financials
A large share of the portfolio is invested in financial companies, so the fund could be hit hard if that sector faces a downturn.
Limited Geographic Diversification
With the vast majority of its holdings in U.S. stocks and only a small allocation to Canada, the ETF offers little exposure to other global markets.

UDI vs. SPDR S&P 500 ETF (SPY)

UDI Summary

The USCF Dividend Income Fund (UDI) is an ETF that invests across the broad U.S. and Canadian stock market with a special focus on companies that pay dividends, rather than tracking a specific index. It holds a mix of sectors like financials, health care, and energy, with well-known names such as Johnson & Johnson and Citigroup in the portfolio. Someone might invest in UDI to seek regular dividend income while still getting diversified stock market exposure. A key risk is that stock prices and dividend payments can go up and down with the overall market.
How much will it cost me?The USCF Dividend Income Fund (Ticker: UDI) has an expense ratio of 0.65%, meaning you’ll pay $6.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, focusing on carefully selecting dividend-paying stocks rather than tracking a broad index. Active management typically involves higher costs due to the research and decision-making required.
What would affect this ETF?The USCF Dividend Income Fund (UDI) could benefit from stable or declining interest rates, which often make dividend-paying stocks more attractive to investors, as well as continued growth in the healthcare and technology sectors, where it has significant exposure. However, rising interest rates or economic slowdowns could negatively impact the fund, particularly its financial and real estate holdings, which are sensitive to such conditions. Additionally, regulatory changes or sector-specific challenges in healthcare or financials could pose risks to its performance.

UDI Top 10 Holdings

This dividend-focused ETF leans heavily on U.S. financials, with banks like State Street and Citigroup doing much of the heavy lifting as their shares have been steadily rising and giving the fund a solid backbone. East West Bancorp is also pulling its weight, adding to the financial momentum. On the income side, healthcare names tell a mixed story: AbbVie is climbing, but Medtronic has been lagging and acting like a small anchor. Energy and utilities, via ConocoPhillips and Exelon, are more of a steady hum than a growth engine, keeping the fund’s U.S.-centric profile balanced but not overly flashy.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Johnson & Johnson4.56%$188.53K$633.19B71.54%
78
Outperform
AbbVie4.35%$179.86K$461.26B34.19%
66
Neutral
State Street3.92%$161.88K$47.24B61.14%
75
Outperform
East West Bancorp3.53%$145.96K$17.71B20.60%
79
Outperform
Lamar Advertising3.28%$135.41K$15.99B29.54%
72
Outperform
Conocophillips3.28%$135.38K$127.59B13.20%
78
Outperform
Medtronic3.12%$129.08K$106.49B-5.36%
80
Outperform
Phillips 663.00%$123.95K$70.73B36.41%
73
Outperform
Citigroup2.98%$123.29K$240.04B64.51%
68
Neutral
Exelon2.89%$119.22K$48.99B10.63%
67
Neutral

UDI Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
34.97
Positive
100DMA
34.43
Positive
200DMA
32.88
Positive
Market Momentum
MACD
0.32
Negative
RSI
62.14
Neutral
STOCH
82.69
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For UDI, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.63, equal to the 50-day MA of 34.97, and equal to the 200-day MA of 32.88, indicating a bullish trend. The MACD of 0.32 indicates Negative momentum. The RSI at 62.14 is Neutral, neither overbought nor oversold. The STOCH value of 82.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UDI.

UDI Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$4.15M0.65%
73
Outperform
$96.79M0.89%
72
Outperform
$96.27M0.75%
68
Neutral
$91.70M0.65%
66
Neutral
$86.31M0.52%
71
Outperform
$79.77M0.59%
69
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
UDI
USCF Dividend Income Fund
36.15
6.44
21.68%
BAMD
Brookstone Dividend Stock ETF
SOVF
Sovereign's Capital Flourish Fund
YALL
God Bless America ETF
RFDA
RiverFront Dynamic US Dividend Advantage ETF
PFOE
Pathfinder Focused Opportunities ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement